Skip to Main Content

Paper Details

MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.
Blood
6
2022
B-ALL, B-ALL cells, Cancer, Cancer cells, Cas9, Glutamine, MLXIP, MYC, MondoA, PDH, TCA, malignancy, mouse, patient, pediatric B-ALL, pediatric common acute lymphoblastic leukemia, tricarboxylic acid
Author NameAffiliation
G??nther H S RichterChildren's Cancer Research Center
G??nther H S RichterComprehensive Cancer Center (CCC) Munchen and Deutsches Konsortium fur Translationale Krebsforschung (DKTK)
G??nther H S RichterChildren's Cancer Research Center
G??nther H S RichterComprehensive Cancer Center (CCC) Munchen and Deutsches Konsortium fur Translationale Krebsforschung (DKTK)
Thomas G P Gr??newaldInstitute of Pathology, Ludwig-Maximilians-Universitat (LMU) Munchen
Thomas G P Gr??newaldComprehensive Cancer Center (CCC) Munchen and Deutsches Konsortium fur Translationale Krebsforschung (DKTK)
Poul H SorensenChildren's Cancer Research Center
Poul H SorensenBritish Columbia Cancer Research Centre
Poul H SorensenChildren's Cancer Research Center
Poul H SorensenBritish Columbia Cancer Research Centre
Stefan BurdachChildren's Cancer Research Center
Stefan BurdachComprehensive Cancer Center (CCC) Munchen and Deutsches Konsortium fur Translationale Krebsforschung (DKTK)
Stefan BurdachBritish Columbia Cancer Research Centre
Stefan BurdachChildren's Cancer Research Center
Stefan BurdachComprehensive Cancer Center (CCC) Munchen and Deutsches Konsortium fur Translationale Krebsforschung (DKTK)
Stefan BurdachBritish Columbia Cancer Research Centre
  • 1 - 16

Datasets

Release 1.2